313 related articles for article (PubMed ID: 18056981)
1. Interleukin-6 and cachexia in ApcMin/+ mice.
Baltgalvis KA; Berger FG; Pena MM; Davis JM; Muga SJ; Carson JA
Am J Physiol Regul Integr Comp Physiol; 2008 Feb; 294(2):R393-401. PubMed ID: 18056981
[TBL] [Abstract][Full Text] [Related]
2. Activity level, apoptosis, and development of cachexia in Apc(Min/+) mice.
Baltgalvis KA; Berger FG; Peña MM; Mark Davis J; White JP; Carson JA
J Appl Physiol (1985); 2010 Oct; 109(4):1155-61. PubMed ID: 20651218
[TBL] [Abstract][Full Text] [Related]
3. Sex differences in the relationship of IL-6 signaling to cancer cachexia progression.
Hetzler KL; Hardee JP; Puppa MJ; Narsale AA; Sato S; Davis JM; Carson JA
Biochim Biophys Acta; 2015 May; 1852(5):816-25. PubMed ID: 25555992
[TBL] [Abstract][Full Text] [Related]
4. Muscle oxidative capacity during IL-6-dependent cancer cachexia.
White JP; Baltgalvis KA; Puppa MJ; Sato S; Baynes JW; Carson JA
Am J Physiol Regul Integr Comp Physiol; 2011 Feb; 300(2):R201-11. PubMed ID: 21148472
[TBL] [Abstract][Full Text] [Related]
5. Myofiber degeneration/regeneration is induced in the cachectic ApcMin/+ mouse.
Mehl KA; Davis JM; Berger FG; Carson JA
J Appl Physiol (1985); 2005 Dec; 99(6):2379-87. PubMed ID: 16288100
[TBL] [Abstract][Full Text] [Related]
6. Muscle wasting and interleukin-6-induced atrogin-I expression in the cachectic Apc ( Min/+ ) mouse.
Baltgalvis KA; Berger FG; Peña MM; Davis JM; White JP; Carson JA
Pflugers Arch; 2009 Mar; 457(5):989-1001. PubMed ID: 18712412
[TBL] [Abstract][Full Text] [Related]
7. Quercetin supplementation attenuates the progression of cancer cachexia in ApcMin/+ mice.
Velázquez KT; Enos RT; Narsale AA; Puppa MJ; Davis JM; Murphy EA; Carson JA
J Nutr; 2014 Jun; 144(6):868-75. PubMed ID: 24759931
[TBL] [Abstract][Full Text] [Related]
8. Short-term pyrrolidine dithiocarbamate administration attenuates cachexia-induced alterations to muscle and liver in ApcMin/+ mice.
Narsale AA; Puppa MJ; Hardee JP; VanderVeen BN; Enos RT; Murphy EA; Carson JA
Oncotarget; 2016 Sep; 7(37):59482-59502. PubMed ID: 27449092
[TBL] [Abstract][Full Text] [Related]
9. The regulation of skeletal muscle protein turnover during the progression of cancer cachexia in the Apc(Min/+) mouse.
White JP; Baynes JW; Welle SL; Kostek MC; Matesic LE; Sato S; Carson JA
PLoS One; 2011; 6(9):e24650. PubMed ID: 21949739
[TBL] [Abstract][Full Text] [Related]
10. JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia.
Bonetto A; Aydogdu T; Jin X; Zhang Z; Zhan R; Puzis L; Koniaris LG; Zimmers TA
Am J Physiol Endocrinol Metab; 2012 Aug; 303(3):E410-21. PubMed ID: 22669242
[TBL] [Abstract][Full Text] [Related]
11. Lymphodepletion in the ApcMin/+ mouse model of intestinal tumorigenesis.
Coletta PL; Müller AM; Jones EA; Mühl B; Holwell S; Clarke D; Meade JL; Cook GP; Hawcroft G; Ponchel F; Lam WK; MacLennan KA; Hull MA; Bonifer C; Markham AF
Blood; 2004 Feb; 103(3):1050-8. PubMed ID: 14525778
[TBL] [Abstract][Full Text] [Related]
12. MMP12 knockout prevents weight and muscle loss in tumor-bearing mice.
Jiang L; Yang M; He S; Li Z; Li H; Niu T; Xie D; Mei Y; He X; Wei L; Huang P; Huang M; Zhang R; Wang L; Li J
BMC Cancer; 2021 Dec; 21(1):1297. PubMed ID: 34863141
[TBL] [Abstract][Full Text] [Related]
13. Cachectic skeletal muscle response to a novel bout of low-frequency stimulation.
Puppa MJ; Murphy EA; Fayad R; Hand GA; Carson JA
J Appl Physiol (1985); 2014 Apr; 116(8):1078-87. PubMed ID: 24610533
[TBL] [Abstract][Full Text] [Related]
14. Loss of single immunoglobulin interlukin-1 receptor-related molecule leads to enhanced colonic polyposis in Apc(min) mice.
Xiao H; Yin W; Khan MA; Gulen MF; Zhou H; Sham HP; Jacobson K; Vallance BA; Li X
Gastroenterology; 2010 Aug; 139(2):574-85. PubMed ID: 20416302
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of intestinal polyposis with reduced angiogenesis in ApcMin/+ mice due to decreases in c-Myc expression.
Yekkala K; Baudino TA
Mol Cancer Res; 2007 Dec; 5(12):1296-303. PubMed ID: 18171987
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory signalling regulates eccentric contraction-induced protein synthesis in cachectic skeletal muscle.
Hardee JP; Counts BR; Gao S; VanderVeen BN; Fix DK; Koh HJ; Carson JA
J Cachexia Sarcopenia Muscle; 2018 Apr; 9(2):369-383. PubMed ID: 29215198
[TBL] [Abstract][Full Text] [Related]
17. Hypothalamic-pituitary-adrenal axis activation and glucocorticoid-responsive gene expression in skeletal muscle and liver of Apc mice.
Martin A; Castells J; Allibert V; Emerit A; Zolotoff C; Cardot-Ruffino V; Gallot YS; Vernus B; Chauvet V; Bartholin L; Schaeffer L; Durieux AC; Hourdé C; Favier FB; Mazelin L; Freyssenet D
J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1686-1703. PubMed ID: 35277933
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the male ApcMin/+ mouse as a hypogonadism model related to cancer cachexia.
White JP; Puppa MJ; Narsale A; Carson JA
Biol Open; 2013 Dec; 2(12):1346-53. PubMed ID: 24285707
[TBL] [Abstract][Full Text] [Related]
19. Treatment with anti-interleukin-6 receptor antibody ameliorates intestinal polyposis in Apc(Min/+) mice under high-fat diet conditions.
Yaoita T; Sasaki Y; Yokozawa J; Sato T; Kanno N; Sakuta K; Yagi M; Yoshizawa K; Iwano D; Nagino K; Nomura E; Abe Y; Nishise S; Takeda H; Kawata S; Ueno Y
Tohoku J Exp Med; 2015 Feb; 235(2):127-34. PubMed ID: 25746084
[TBL] [Abstract][Full Text] [Related]
20. Administration of adiponectin receptor agonist AdipoRon relieves cancer cachexia by mitigating inflammation in tumour-bearing mice.
Massart IS; Kouakou AN; Pelet N; Lause P; Schakman O; Loumaye A; Abou-Samra M; Deldicque L; Bindels LB; Brichard SM; Thissen JP
J Cachexia Sarcopenia Muscle; 2024 Apr; ():. PubMed ID: 38572511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]